Novavax Inc (NVAX) earnings · rev $1.12B
These earnings events as JSON? API free 100/dayNovavax Inc (NVAX) is a biotechnology company listed on US.
This NVAX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NVAX revenue for 2025-12-31 was $1.12B. Net income was $440.3M. Revenue was up 64.7% from 2024-12-31 to 2025-12-31. NVAX currently screens at market cap $1.09B.
When the next NVAX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 64.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NVAX research stays on the stock page; the tape stays on the quote page.
NVAX earnings FAQ
What are NVAX's latest revenue and net income?
Latest cached Novavax Inc (NVAX) revenue for Dec 31, 2025 was $1.12B. Net income was $440.3M. Statements: https://lician.com/financials/nvax
What is NVAX's latest diluted EPS?
Latest cached Novavax Inc (NVAX) diluted EPS for Dec 31, 2025 was $2.58.
What period does the latest NVAX earnings print cover?
The latest cached Novavax Inc (NVAX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did NVAX revenue change from the prior cached period?
Cached Novavax Inc (NVAX) revenue was up 64.7% from $682.2M (Dec 31, 2024) to $1.12B (Dec 31, 2025). Statements: https://lician.com/financials/nvax
Where are NVAX earnings listed?
Cached earnings facts for Novavax Inc (NVAX) are listed at https://lician.com/earnings/nvax. Statements: https://lician.com/financials/nvax
Not investment advice.